FIRINU, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 218.019
NA - Nord America 9.114
AS - Asia 4.800
SA - Sud America 971
AF - Africa 152
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 5
Totale 233.082
Nazione #
IT - Italia 215.024
US - Stati Uniti d'America 8.915
SG - Singapore 1.903
CN - Cina 1.696
BR - Brasile 802
SE - Svezia 709
DE - Germania 576
UA - Ucraina 435
VN - Vietnam 373
FI - Finlandia 329
GB - Regno Unito 280
FR - Francia 159
KR - Corea 129
HK - Hong Kong 128
NL - Olanda 124
CA - Canada 116
IN - India 104
TR - Turchia 70
AT - Austria 68
AR - Argentina 62
BD - Bangladesh 54
MX - Messico 53
JP - Giappone 51
RU - Federazione Russa 47
ZA - Sudafrica 47
ID - Indonesia 42
ES - Italia 41
IE - Irlanda 39
PL - Polonia 33
MA - Marocco 32
IR - Iran 30
CO - Colombia 25
IQ - Iraq 25
BE - Belgio 24
PK - Pakistan 23
EC - Ecuador 21
UZ - Uzbekistan 19
SA - Arabia Saudita 18
VE - Venezuela 18
AU - Australia 17
CL - Cile 16
EG - Egitto 16
IL - Israele 16
KE - Kenya 13
PH - Filippine 13
AE - Emirati Arabi Uniti 12
LT - Lituania 12
PT - Portogallo 12
RO - Romania 12
MY - Malesia 11
TW - Taiwan 11
CZ - Repubblica Ceca 10
JO - Giordania 10
CH - Svizzera 9
DZ - Algeria 8
PE - Perù 8
TH - Thailandia 8
AZ - Azerbaigian 7
DK - Danimarca 7
NG - Nigeria 7
TN - Tunisia 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
GR - Grecia 6
HU - Ungheria 6
KZ - Kazakistan 6
NO - Norvegia 6
NP - Nepal 6
PY - Paraguay 6
AL - Albania 5
BG - Bulgaria 5
CI - Costa d'Avorio 5
CR - Costa Rica 5
EE - Estonia 5
GE - Georgia 5
MK - Macedonia 5
BN - Brunei Darussalam 4
BO - Bolivia 4
EU - Europa 4
IS - Islanda 4
KG - Kirghizistan 4
LU - Lussemburgo 4
LV - Lettonia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
RS - Serbia 4
SN - Senegal 4
CG - Congo 3
HN - Honduras 3
HR - Croazia 3
KW - Kuwait 3
LB - Libano 3
AO - Angola 2
BB - Barbados 2
ET - Etiopia 2
GI - Gibilterra 2
JM - Giamaica 2
LC - Santa Lucia 2
Totale 233.049
Città #
Cagliari 208.726
Uta 5.126
Ashburn 1.023
Singapore 871
Fairfield 799
Dallas 765
Woodbridge 559
Chandler 534
Boardman 522
Houston 467
Nyköping 405
Beijing 383
Wilmington 326
Seattle 286
Cambridge 251
Ann Arbor 246
Munich 237
Helsinki 223
Los Angeles 217
Jacksonville 205
Hefei 186
Santa Clara 163
Shanghai 158
New York 154
Hong Kong 115
Seoul 115
Boston 111
Dearborn 110
Dong Ket 102
Rome 102
Ho Chi Minh City 93
Nanjing 83
The Dalles 83
Milan 77
São Paulo 77
Buffalo 73
San Diego 72
Redwood City 65
Redondo Beach 64
Hanoi 62
Guangzhou 57
London 50
Toronto 50
Frankfurt am Main 45
Chicago 44
Nuremberg 44
Vienna 43
Brooklyn 39
Washington 38
Tokyo 35
Amsterdam 34
Council Bluffs 34
Chennai 33
Nanchang 31
Atlanta 30
Changsha 30
Montreal 30
Rio de Janeiro 30
Tianjin 30
Verona 29
Paris 28
Johannesburg 27
Dublin 26
Jiaxing 25
Shenyang 25
Stockholm 24
Sassari 23
Warsaw 23
Casablanca 22
Denver 22
Düsseldorf 21
Kocaeli 21
Lappeenranta 21
Monserrato 21
Zhengzhou 21
Ankara 20
Birmingham 20
Mexico City 20
Phoenix 20
San Francisco 20
Turku 20
Belo Horizonte 19
Brussels 19
Mountain View 19
Tashkent 19
Norwalk 18
Curitiba 17
Redmond 17
Turin 17
Columbus 16
Jakarta 16
Orem 16
San Jose 16
Bari 15
Haiphong 15
Vicenza 15
Wuhan 15
Brasília 14
Florence 14
Hebei 14
Totale 225.773
Nome #
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 20.757
Overexpression of the cytokine BAFF and autoimmunity risk 4.057
TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome 3.982
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 3.832
The salivary proteome profile in patients affected by SAPHO syndrome characterized by a top-down RP-HPLC-ESI-MS platform 3.815
Systemic lupus erythematosus occurring in a patient with Niemann-Pick type B disease. 3.507
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management 3.227
Zinc status and autoimmunity: A systematic review and meta-analysis 3.062
The Salivary Proteome Profile in Patients Affected by SAPHO Syndrome characterized by a top-down RP-HPLC-ESI-MS platform 2.958
Vaping effects on asthma: results from a web survey and clinical investigation 2.933
Characterization of patients with angioedema without wheals: The importance of F12 gene screening 2.738
COVID-19 in the mediterranean area: Epidemiology and main disease characteristics - A narrative review 2.727
Proteomic Analysis of the Acid-Insoluble Fraction of Whole Saliva from Patients Affected by Different Forms of Non-histaminergic Angioedema 2.726
Fungal allergy in asthma 2.712
Alteration of the salivary secretory proteome profile in adults affected by antibody deficiency diseases 2.693
Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis 2.677
Exercise-induced anaphylaxis with an Ayurvedic drug as cofactor: A case report 2.671
SAPHO Syndrome: Current developments and approaches to clinical treatment 2.667
RP-HPLC-ESI-IT Mass Spectrometry Reveals Significant Variations of the Human Salivary Protein Profile Associated with Predominantly Antibody Deficiencies 2.594
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 2.507
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 2.425
Biological treatments for SAPHO syndrome: an update 2.411
Evaluation of olfactory function as a potential biomarker in patients with Mastocytosis 2.398
Impaired endothelial function in hereditary angioedema during the symptom-free period 2.392
Baricitinib exposure during pregnancy in rheumatoid arthritis 2.284
Oxidative stress markers in patients with hereditary angioedema 2.265
Alteration of the Salivary Secretory Proteome Profile in Adults Affected by Immune Deficiency Diseases 2.236
Increased peripheral T(H)17 Cells in SAPHO syndrome: a novel target for treatment? 2.192
Biologics for ANCA-associated vasculitis 2.179
Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie = Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic 2.176
Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study 2.133
Genetic variants regulating immune cell levels in health and disease 2.095
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.968
Clinical pitfalls of leishmaniasis and Whipple’s disease hidden behind systemic lupus erythematosus: A case series 1.966
An uncommon cause of refractory pleural effusion in an elderly patient 1.965
Periodic fever syndromes and autoinflammatory diseases: a case series from an Italian centre 1.957
The role of genetics in the current diagnostic workup of idiopathic non-histaminergic angioedema 1.897
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 1.896
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather? 1.871
Mutation of angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema 1.789
Asthma and psychiatric disorders 1.755
Relevance of essential trace elements in nutrition and drinking water for human health and autoimmune disease risk 1.751
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma 1.734
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 1.712
Genetic factors associated with levels of immune cell types 1.682
The climate in the European Union and the enlarged European Region is a determinant of the COVID-19 case fatality ratio 1.667
Influenza burden, prevention and treatment in asthma - a scoping review by the EAACI Influenza in Asthma Task Force 1.637
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.629
EAACI Biologicals Guidelines—Recommendations for severe asthma 1.596
Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery 1.589
Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole 1.561
Exercise and asthma: an overview 1.557
Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency: a case report 1.538
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma 1.506
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype 1.502
Is hereditary angioedema related to an increased risk of atherosclerosis? 1.501
The COVID-19 incidence in Italian regions correlates with low temperature, mobility and PM10 pollution but lethality only with low temperature 1.494
Management of Intermittent and Persistent Asthma in Adolescent and High School Athletes 1.450
Hyperosinophilia and recurrent angioedema in a patient with giant cell arteritis: a diagnostic "glitch" in a case of Gleich's syndrome 1.436
A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout 1.414
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 1.402
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.400
Celiac disease: peripheral blood cell-mediated response to antigen-specific stimulation 1.359
Exercise training, lymphocyte subsets and their cytokines production: experience of an Italian professional football team and their impact on allergy 1.353
Biologics for SAPHO syndrome: a single centre experience 1.339
Eosinophilic granulomatosis with polyangiitis relapse after covid-19 vaccination: A case report 1.318
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination 1.297
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 1.286
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 1.240
Melkersson-Rosenthal Syndrome: A case report 1.219
Metabolomics, microbiota, and in vivo and in vitro biomarkers in type 2 severe asthma: A perspective review 1.217
COVID-19 Case Fatality Ratio of Latino America Countries with Temperate Climate Partially Follows European and Oceania Trends According to Seasonal Change 1.209
An uncommon association of antiphospholipid syndrome, selective IgA deficiency and resistant-to-treatment relapsing polychondritis: efficacy of Infliximab 1.207
Urticaria and angioedema as possible misleading skin symptoms in families with hereditary angioedema 1.204
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor 1.190
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.182
Olfactory Function Is Impaired in Patients with Mastocytosis 1.169
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 1.165
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma 1.158
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 1.143
Idiopathic pyoderma gangrenosum: Successful resolution with Infliximab therapy and proinflammatory cytokines assessment 1.140
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor 1.107
Angioedema without wheals: a retrospective analysis of a single center cohort 1.105
Raynaud's phenomenon and scleroderma associated with silicone gel breast implants: An example of Asia syndrome 1.093
Oxidative stress in hereditary angioedema caused by C1 inhibitor deficiency: An interesting finding that deserves further studies 1.068
Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency 1.061
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G 1.031
Adult antibody deficiency syndrome and Henoch-Schoenlein Purpura: a report of two cases 1.014
Previous functional social and behavioral rhythms affect resilience to COVID-19-related stress among old adults 1.008
Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab 993
Salivary Cystatin D Interactome in Patients with Systemic Mastocytosis: An Exploratory Study 993
A promising new treatment for SAPHO syndrome that deserves further studies 975
Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: A case report 969
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 964
A Novel Mutation in the SERPING1 Gene in Patients with Hereditary Angioedema and a Coexistent Complement Deficiency 904
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic. Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H 899
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study 866
Cofactors, age at onset, allergic comorbidities and gender are different in patients sensitized to omega-5 gliadin and Pru p 3 861
COVID-19 Vaccine Hesitancy among Italian Healthcare Workers: Latent Profiles and Their Relationships to Predictors and Outcome 843
Aspects of hereditary angioedema genotyping in the era of NGS: The case of F12 gene = Wybrane aspekty genotypowania wrodzonego obrzȩku naczynioruchowego w erze NGS: Gen F12 833
Totale 197.832
Categoria #
all - tutte 304.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 304.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119.873 0 0 0 0 0 5.090 3.203 3.109 1.519 2.594 2.618 1.740
2021/202212.565 1.277 721 586 986 922 896 795 607 1.311 1.144 1.659 1.661
2022/202317.536 1.347 2.302 2.432 1.366 1.532 1.814 944 1.546 1.052 991 1.336 874
2023/202420.785 1.275 781 979 1.614 1.945 3.424 3.046 1.666 992 1.354 1.797 1.912
2024/202575.152 15.887 35.053 7.619 4.366 3.292 2.562 3.563 358 665 526 496 765
2025/20266.332 950 811 1.469 1.052 1.169 881 0 0 0 0 0 0
Totale 233.783